Infants with biotinidase deficiency appear normal at birth, but develop serious symptoms after the first few weeks or months of life. Symptoms include low muscle tone, seizures, developmental delay, loss or absence of hair, hearing loss and optic nerve atrophy. These symptoms can become serious enough to lead to coma and death. With early diagnosis and treatment, all symptoms can be prevented.
Biotinidase is a genetic condition caused by changes in the BTD (Biotinidase) gene. The BTD gene is responsible for making the enzyme called biotinidase. Biotinidase frees the bound biotin in protein. This free biotin can then help carboxylases make fats, carbohydrates, and break down protein. When there is an alteration in the BTD gene, biotinidase levels go down and the free biotin is too low.
Biotinidase deficiency is inherited in an autosomal recessive pattern, which means two copies of the BTD gene must be changed for a person to be affected with biotinidase. Most often, the parents of a child with an autosomal recessive condition are not affected because they are “carriers”, with one copy of the changed BTD gene and one copy of the normal BTD gene .
When both parents are carriers, there is a one-in-four (or 25 percent) chance that both will pass a changed BTD gene on to a child, causing the child to be born with the condition. There also is a one-in-four (or 25 percent) chance that they will each pass on a normal BTD gene , and the child will be free of the condition. There is a two-in-four (or 50 percent) chance that a child will inherit a changed BTD gene from one parent and a normal BTD gene from the other, making it a carrier like its parents. These chances are the same in each pregnancy for these parents.
Yes. Babies are tested (newborn screening) for biotinidase deficiency before they leave the hospital. The baby’s heel is pricked and a few drops of blood are taken. The blood is sent to the state laboratory to find out if it has less than a normal amount the biotinidase enzyme.
Yes. Generally, taking a daily dose of free (or unbound) biotin can prevent the symptoms of biotinidase deficiency. However, hearing problems may occur in spite of treatment. Treatment should begin as soon as possible following a diagnosis and will continue throughout an individual’s life. Children and adults with biotinidase deficiency require follow-up care at a medical center or clinic that specialize in this condition. In addition, regular blood tests are used to monitor your child’s health.
The information contained on this page is not intended to replace the advice of a genetic metabolic medical professional.
Biotinidase Deficiency: A Booklet for Families and Professionals
www.ccmckids.org/research/biotinidase/
MUMS National Parent-to-Parent Network
Julie J. Gordon
150 Custer Court
Green Bay, Wisconsin 54301-1243
Phone: 1-877-336-5333 (Parents only please)
Phone: 1-920-336-5333
Fax: 1-920-339-0995
E-mail: mums@netnet.net
www.netnet.net/mums/
Association for Neuro-Metabolic Disorders
5223 Brookfield Lane
Sylvania OH 43560-1809
Phone: 419-885-1497
E-mail: VOLK4OLKS@aol.com
GeneTests (Biotinidase Deficiency) http://www.geneclinics.org
Online Mendelian Inheritance in Man (OMIM topics 253260)
http://www.ncbi.nlm.nih.gov/Omim
Scriver, C.R. and Kaufman, S (2001) Disorders of Biotin Metabolism. In: Scriver, C.R., Kaufman, S., Eisensmith, E., Woo S.L.C., Vogelstein, B. Childs, B. (eds)
The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, Ch.156 pg. 3947-3956.
Wolf, B. (2003) Biotinidase Deficiency: New Direction and Practical Concerns. Current Treatment Options in Neurology 5(4): 321-328.